Background:
Breast carcinoma is a malignant disease that represents the most common non-skin malignancy
and a chief reason of cancer death in women. Large interest is growing in the use of natural products for cancer treatment,
especially with goal of suppression angiogenesis, tumor cell growth, motility, as well as invasion and metastasis with
low/no toxicity. It is evident from recent patents on the anticancer properties of sesquiterpene lactones such as
parthenolide.
Objective:
In this study, using MDA-MB-231 cells of a human breast adenocarcinoma, the effects of aguerin B, as a
natural sesquiterpene lactone, has been evaluated, in terms of the expression of metastatic-related genes (Pak-1, Rac-1 and
HIF-1α).
Methods:
Cytotoxicity of aguerin B was tested toward MDA-MB-231 breast tumor cells using MTT. Scratch assay was
accomplished to evaluate the tumor cell invasion. To understand the underlying molecular basis, the mRNA expressions
were evaluated by real time PCR.
Results:
It was found that aguerin B significantly inhibited human breast cancer cell growth in vitro (IC50 = 2µg/mL) and
this effect was accompanied with a persuasive suppression on metastasis. Our results showed that aguerin B in IC50
concentration down-regulated Rac-1, Pak-1, Hif-1α and Zeb-1 transcriptional levels.
Conclusion:
Taken together, this study demonstrated that aguerin B possessed potential anti-metastatic effect, suggesting
that it may consider as a potential multi target bio compound for treatment of breast metastatic carcinoma.